Table 3.
Comparison of the repartition of the distinct immune profiles for each clinical context.
| Endometrial immune profiling | Before OD | Before IVF | RIF-OD | RIF | RM | Average repartition |
|---|---|---|---|---|---|---|
| Number of patients | 91 | 210 | 128 | 1145 | 164 | – |
| No dysregulation | 20.9% [19/91] |
12.4% [26/210] |
11.6% [15/128] |
17.2% [197/1145] |
19.5% [32/164] |
289 (16.6%) |
| Immune under-activation | 25.3% [23/91] |
34.3% [72/210] |
33.6% [43/128] |
27.2% [311/1145] |
23.2% [38/164] |
487 (28%) |
| Immune over-activation | 39.6% [36/91] |
43.8% [92/210] |
43.7% [56/128] |
45.9% [525/1145] |
45.1% [74/164] |
783 (45.1%) |
| Mixed profile | 14.3% [13/91] |
9.5% [20/210] |
10.9% [14/128] |
9.8% [112/1145] |
12.2% [20/164] |
179 (10.3%) |
RIF, Repeated Implantation Failures; IVF, In vitro Fertilization; RM, Recurrent Miscarriages; OD, Oocyte Donation.